2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Complications Metabolic

32.12 - Post Renal Transplant Proteinuria-Indian Study

Presenter: deepak, sharma, panchkula, India
Authors: sharma d.

POST RENAL TRANSPLANT PROTEINURIA-INDIAN STUDY

COMPLICATIONS - METABOLIC

D. Sharma
Nephrology, command hospital, panchkula/INDIA

Body: Post Renal Transplant Proteinuria-an Indian study
Deepak Sharma#,
#Dept of Nephrology,Medical Division,Command Hospital(Chandimandir), PANCHKULA,India Introduction- Proteinuria is quite common ,occurring in upto 50% of patients, resulting in decreased patient and allograft survival and increased prevalence cardiovascular disease. ACE inhibitors(ACEI) & Angiotensin receptor blockers(ARB) have been the mainstay of therapy in native kidney proteinuria,though may not succeed in all patients because of side effects..Pentoxyfylline has been advocated as an anti-inflammatory measure,probably contributing to amelioration of proteinuria.
Aim-To study the effects of Telmisartan,Ramipril & Pentoxyfylline on Proteinuria in Renal transplant recipients.
Methods- A total of 72 Renal transplant recipients having proteinuria of 300 mg/24hr or more with stable GFR of 42ml/min to 70ml/min were studied from Sep 2006 to Sept 2009 at a tertiary care nephrology centre. The patients in groupA (total 51 received Ramipril,Telmisartan for six months & Pentoxifylline was added due to persistence of significant proteinuria.In 11 patients receiving Ramipril(groupB) Pentoxifylline was added due to persistence of proteinuria beyond six months. 10 patients (Group C)were given Telmisartan alone for six months & then received Pentoxifylline in addition for another three months. Results- In group A proteinuria (p=0.001),albuminuria(p=0.005) & urinary albumin to creatinine ratio(ACR,P=0.005) declined& serum potassium(p=0.95) did not increase significantly.In group B proteinuria(p=0.015) , ,albuminuria(p=0.001)& ACR(0.019) decreased & there was no(p=0.78) significant elevation in potassium.In serum groupC proteinuria(p=0.017),albuminuria(p=0.011)& ACR(P=0.007) decreased significantly& there was no(p=0.98) significant elevation in serum potassium.Serum creatinine in all the groups was (p=0.030)stable.GFR correlated positively with changes in albuminuria which in turn correlated negatively(p=0.005) with serum creatinine.Changes in ACR correlated negatively with serum creatinine(p=0.020) in all groups.
Conclusion-The present study reveals the benefit of using Pentoxifylline in combination with ACEI&ARB resulting in significant decline of proteinuria,albuminuria & improvement of GFR especially in patients having persistence of proteinuria despite using ACEI &/orARB.There was no significant hyperkalemia noted in this study. All the drugs(Ramipril,Telmisartan& Pentoxifylline) were well tolerated.


Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada